Clinical aspects of ovarian hyperstimulation syndrome

被引:34
|
作者
Schenker, JG [1 ]
机构
[1] Hadassah Med Ctr, Dept Obstet & Gynecol, IL-91120 Jerusalem, Israel
关键词
ovarian hyperstimulation; pregnancy; prostaglandins; cytokines; vascular endothelial growth factor;
D O I
10.1016/S0301-2115(98)00276-0
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Ovarian hyperstimulation syndrome (OHSS) is characterized by massive transudation of protein-rich fluid (mainly albumin) from the vascular space into the peritoneal pleural and to a lesser extent to the pericardial cavities. The intensity of the syndrome is related to the degree of the follicular response in the ovaries to the ovulation inducing agents. OHSS is still a threat to every patient undergoing ovulation induction. The pathophysiology of OHSS is of extreme importance in the face of the increased use of ovulation induction agents as well as the development of sophisticated assisted reproductive techniques. The correlation found between plasma cytokine activities and the severity of OHSS suggests that plasma cytokines may be involved in the pathogenesis of OHSS and may serve as a means of monitoring the syndrome during the acute phase and throughout convalescence. The interactions between cytokine and non-cytokine mediators of the syndrome, such as the renin-angiotensin system and vascular endothelial growth factor were recently clarified. Awareness of possible mechanisms and factors in the pathophysiology of OHSS will hopefully provide opportunities to design specific treatment regimens effective for both prevention and treatment of this potentially fatal iatrogenic condition. Among IVF patients with severe and critical OHSS, pregnancy rates, multiple gestations, miscarriage, preterm premature rupture of the membranes, prematurity, and low birth weight rates are significantly higher than those reported previously for pregnancies after assisted conception. The incidence of other obstetrical complications, as well as congenital malformations and Cesarean section rates are not significantly different. (C) 1999 Elsevier Science ireland Ltd. All rights reserved.
引用
收藏
页码:13 / 20
页数:8
相关论文
共 50 条
  • [31] Ovarian hyperstimulation syndrome
    Tassone, M
    Kuhn, R
    Talbot, JM
    [J]. AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 1997, 37 (01): : 95 - 99
  • [32] Clinical Features of Severe Ovarian Hyperstimulation Syndrome with Hydrothorax
    Ma, Xiaowei
    Yin, Jingwen
    Yang, Rui
    Yang, Shuo
    Li, Jia
    Wang, Yang
    Li, Rong
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (19)
  • [33] Ovarian hyperstimulation syndrome
    Delbeke, LOC
    [J]. HUMAN REPRODUCTION, 1997, 12 : O100 - O100
  • [34] Ovarian hyperstimulation syndrome
    Rosenberg, Hans
    Rangwala, Sohil
    Magee, Bryden
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2024, 196 (29) : E1012 - E1012
  • [35] OVARIAN HYPERSTIMULATION SYNDROME
    MARQUES, L
    STUCK, M
    GIGON, U
    PIROVINO, M
    [J]. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1991, 121 (21) : 777 - 782
  • [36] THE OVARIAN HYPERSTIMULATION SYNDROME
    KECK, C
    NEULEN, J
    BRECKWOLDT, M
    [J]. GEBURTSHILFE UND FRAUENHEILKUNDE, 1994, 54 (06) : 315 - 320
  • [37] Pathophysiology and current clinical approach of ovarian hyperstimulation syndrome
    Szabo Gabor
    Arokszallasi Aniko
    Pocsi Dora
    Murber Akos
    Urbancsek Janos
    Rigo Janos, Jr.
    [J]. ORVOSI HETILAP, 2018, 159 (34) : 1390 - 1398
  • [38] OVARIAN HYPERSTIMULATION SYNDROME
    BECK, DH
    MASSEY, S
    GRANGER, C
    TAYLOR, BL
    SMITH, GB
    [J]. BRITISH JOURNAL OF ANAESTHESIA, 1995, 75 (03) : 371 - 371
  • [39] OVARIAN HYPERSTIMULATION SYNDROME
    PUTZ, M
    EGARTER, C
    FEICHTINGER, W
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 1993, 105 (24) : 708 - 711
  • [40] The ovarian hyperstimulation syndrome
    Whelan, JG
    Vlahos, NF
    [J]. FERTILITY AND STERILITY, 2000, 73 (05) : 883 - 896